These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5872595)

  • 41. [Chemotherapeutic treatment with progestational hormones in preparation for curietherapy and surgery of adenocarcinoma of the endometrium].
    Bonte J; Drochmans A; Lassance M; Ide P
    Bull Soc R Belge Gynecol Obstet; 1966; 36(6):489-94. PubMed ID: 5990176
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effects of a progestational agent in high doses on the cytology of the oral mucosa].
    Zearo C; Molteni P
    Ann Ostet Ginecol Med Perinat; 1969 Mar; 91(3):213-6. PubMed ID: 5362493
    [No Abstract]   [Full Text] [Related]  

  • 43. [Synthetic progestational hormones in high doses in adenocarcinoma of the endometrium. (Study of carbohydrate metabolism)].
    Pasquinucci C
    Minerva Ginecol; 1970 Oct; 22(19):950-6. PubMed ID: 5516459
    [No Abstract]   [Full Text] [Related]  

  • 44. Endometrial cancer: approach to development of effective chemotherapy.
    Carbone PP; Carter SK
    Gynecol Oncol; 1974 Aug; 2(2-3):348-53. PubMed ID: 4480369
    [No Abstract]   [Full Text] [Related]  

  • 45. Adjuvant chemotherapy for cancer of the corpus uteri. Preliminary report.
    Lewis GC; Nadler SH; Bross ID; Slack NH
    Obstet Gynecol; 1967 Jun; 29(6):797-802. PubMed ID: 5338150
    [No Abstract]   [Full Text] [Related]  

  • 46. [On the etiology and prevention of endometrium carcinoma].
    Kaiser R
    Geburtshilfe Frauenheilkd; 1969 May; 29(5):431-40. PubMed ID: 5772682
    [No Abstract]   [Full Text] [Related]  

  • 47. [Results of surgical, combined and complex treatment of patients with uterine cancer].
    Barinov VV; Kushlinskiĭ NE; Zhordania KI; Peskova VI; Bokina LI; Rotobel'skaia LE
    Vopr Onkol; 1998; 44(5):533-6. PubMed ID: 9884709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Isolated progestational contraception. Advantages and disadvantages].
    Barrat J; Durand-Chène F
    Rev Prat; 1981 Apr; 31(19):1383-9. PubMed ID: 7233018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Alkylating monochemotherapy in the treatment of carcinomas of the uterine cervix and endometrium in advanced phases].
    Alberini L; Perego C
    Minerva Ginecol; 1982; 34(1-2):99-104. PubMed ID: 7078831
    [No Abstract]   [Full Text] [Related]  

  • 50. Adenocarcinoma of the endometrium. A 35-year experience (246 cases).
    Copenhaver EH; Barsamian M
    Lahey Clin Found Bull; 1966; 15(2):65-9. PubMed ID: 5922570
    [No Abstract]   [Full Text] [Related]  

  • 51. [Drug treatment of uterine fibromas].
    Boubli L
    J Gynecol Obstet Biol Reprod (Paris); 1999 Nov; 28(7):729-31. PubMed ID: 10624625
    [No Abstract]   [Full Text] [Related]  

  • 52. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Steroid receptors in normal, hyperplastic and malignant human endometria.
    Vihko R; Jänne O; Kauppila A
    Ann Clin Res; 1980 Oct; 12(5):208-15. PubMed ID: 7015983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [MEDICAL TREATMENT OF CARCINOMA OF THE ENDOMETRIUM].
    RAMOS AV
    An Bras Ginecol; 1964 Jul; 58():19-20. PubMed ID: 14206205
    [No Abstract]   [Full Text] [Related]  

  • 55. Current status of the management of patients with endocrine-sensitive tumors. II. Carcinoma of the prostate, endometrium, thyroid, kidney and miscellaneous tumors.
    Crowley LG; Duwe SA
    Calif Med; 1969 Feb; 110(2):139-50. PubMed ID: 4894628
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of synthetic progestational hormones in gynecologic practice].
    Seroshevski Iu; Komarovska A; Legevski A
    Akush Ginekol (Mosk); 1969 Oct; 45(10):27-8. PubMed ID: 5393459
    [No Abstract]   [Full Text] [Related]  

  • 57. [Gestagen treatment of endometrial carcinoma--theoretical and practical application].
    Sugawa T; Sako H
    Gan To Kagaku Ryoho; 1984 May; 11(5):1005-11. PubMed ID: 6721511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simple biochemical method to assess progestin effects on human endometrial DNA synthesis and its application to endometrial carcinoma.
    King RJ; Raju KS; Siddle NC; Taylor RW; Whitehead MI
    Cancer Res; 1983 Oct; 43(10):5033-6. PubMed ID: 6883350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of ovarian hormones with normal endometrium and endometrial adenocarcinoma.
    Gurpide E; Holinka CF; Fleming H; Fridman O; Deligdisch L; Deppe G
    Mt Sinai J Med; 1980; 47(4):394-7. PubMed ID: 6968031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.